PubMed

Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection.

Schulman KA, Lynn LA, Glick HA, Eisenberg JM.

Ann Intern Med. 1991 May 1;114(9):798-802.PMID: 1672806 [PubMed - indexed for MEDLINE]Related articles

Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.

Langtry HD, Palmer KJ, Benfield P.

Pharmacoeconomics. 1993 Apr;3(4):309-37. Review.PMID: 10146993 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989. PMID: 9440663 [PubMed - indexed for MEDLINE]Related articlesFree article

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

The cost effectiveness of combination antiretroviral therapy for HIV disease.

Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ.

N Engl J Med. 2001 Mar 15;344(11):824-31.PMID: 11248160 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS, et al.

N Engl J Med. 1995 Aug 17;333(7):401-7.PMID: 7616988 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.

Oddone EZ, Cowper P, Hamilton JD, Matchar DB, Hartigan P, Samsa G, Simberkoff M, Feussner JR.

BMJ. 1993 Nov 20;307(6915):1322-5.PMID: 8257887 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group.

Vella S, Giuliano M, Dally LG, Agresti MG, Tomino C, Floridia M, Chiesi A, Fragola V, Moroni M, Piazza M, et al.

J Acquir Immune Defic Syndr. 1994 Jan;7(1):31-8.PMID: 7903380 [PubMed - indexed for MEDLINE]Related articles

Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.

Cook J, Dasbach E, Coplan P, Markson L, Yin D, Meibohm A, Nguyen BY, Chodakewitz J, Mellors J.

AIDS Res Hum Retroviruses. 1999 Apr 10;15(6):499-508.PMID: 10221527 [PubMed - indexed for MEDLINE]Related articles

Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.

Chancellor JV, Hill AM, Sabin CA, Simpson KN, Youle M.

Pharmacoeconomics. 1997 Jul;12(1):54-66.PMID: 10169387 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.

Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M.

JAMA. 1996 Jul 10;276(2):139-45.PMID: 8656506 [PubMed - indexed for MEDLINE]Related articles

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.

Choi S, Lagakos SW, Schooley RT, Volberding PA.

Ann Intern Med. 1993 May 1;118(9):674-80.PMID: 8096373 [PubMed - indexed for MEDLINE]Related articlesFree article

Who should be screened for HIV infection? A cost-effectiveness analysis.

McCarthy BD, Wong JB, Muñoz A, Sonnenberg FA.

Arch Intern Med. 1993 May 10;153(9):1107-16.PMID: 8481077 [PubMed - indexed for MEDLINE]Related articles

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, et al.

N Engl J Med. 1990 Apr 5;322(14):941-9.PMID: 1969115 [PubMed - indexed for MEDLINE]Related articles

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.

Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ.

Ann Intern Med. 1994 Jul 15;121(2):100-8.PMID: 8017721 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.

Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, Testa MA.

N Engl J Med. 1994 Mar 17;330(11):738-43.PMID: 7906386 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Pinkerton SD, Holtgrave DR, Pinkerton HJ.

Arch Intern Med. 1997 Sep 22;157(17):1972-80.PMID: 9308509 [PubMed - indexed for MEDLINE]Related articles

Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Freedberg KA, Tosteson AN, Cotton DJ, Goldman L.

J Gen Intern Med. 1992 May-Jun;7(3):261-72. Review.PMID: 1351940 [PubMed - indexed for MEDLINE]Related articles

Advanced HIV infection treated with zidovudine monotherapy: lifetime values of absolute cost-effectiveness as a pharmacoeconomic reference for future studies evaluating antiretroviral combination treatments. The Osservatorio SIFO sui Farmaci.

Messori A, Becagli P, Berto V, Trippoli S, Font M, Tosolini F, Venturini F, Martini N.

Ann Pharmacother. 1997 Dec;31(12):1447-54.PMID: 9416379 [PubMed - indexed for MEDLINE]Related articles

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.

Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J, et al.

N Engl J Med. 1993 Jul 29;329(5):297-303.PMID: 8100611 [PubMed - indexed for MEDLINE]Related articlesFree article